Drugs - Real World Outcomes

412 papers and 2.9k indexed citations i.

About

The 412 papers published in Drugs - Real World Outcomes in the last decades have received a total of 2.9k indexed citations. Papers published in Drugs - Real World Outcomes usually cover Geriatrics and Gerontology (88 papers), Cardiology and Cardiovascular Medicine (74 papers) and Economics and Econometrics (56 papers) specifically the topics of Pharmaceutical Practices and Patient Outcomes (86 papers), Health Systems, Economic Evaluations, Quality of Life (42 papers) and Pharmacovigilance and Adverse Drug Reactions (38 papers). The most active scholars publishing in Drugs - Real World Outcomes are Maria Gustafsson, Tadashi Toki, Shunsuke Ono, John Marriott, Jörg Mahlich, Tariq M. Alhawassi, Andrew J. McLachlan, Jo‐anne E Brien, Alemayehu Mekonnen and Frank Wiegand.

In The Last Decade

Fields of papers published in Drugs - Real World Outcomes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Drugs - Real World Outcomes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Drugs - Real World Outcomes.

Countries where authors publish in Drugs - Real World Outcomes

Since Specialization
Citations

This map shows the geographic impact of research published in Drugs - Real World Outcomes. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Drugs - Real World Outcomes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drugs - Real World Outcomes more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025